Not Medicare Enrolled
Dr. Joan Siracuse, MD
Cardiovascular Disease · Sebring, FL
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Siracuse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Siracuse?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Siracuse
Dr. Joan Siracuse is a cardiovascular disease specialist in Sebring, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Siracuse performed 5,958 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Siracuse received a total of $6,781 from 31 pharmaceutical and/or device companies across 362 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Siracuse is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 17% volume in FL
$6,781 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,958
Medicare services
Top 17% in FL for cardiovascular disease
Not available
Unique patients (not deduplicated)
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,012 | $44 | $89 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
825 | $10 | $25 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
724 | $88 | $275 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
565 | $61 | $136 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $89 | $192 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
361 | $47 | $113 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
359 | $328 | $546 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
260 | $139 | $285 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
185 | $25 | $75 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
148 | $110 | $230 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
127 | $16 | $29 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
120 | $18 | $28 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
87 | $9 | $28 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
81 | $7 | $25 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
75 | $18 | $26 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
73 | $15 | $50 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
69 | $22 | $33 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
58 | $27 | $67 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
55 | $20 | $68 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
43 | $35 | $182 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
41 | $26 | $77 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
38 | $4 | $11 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
33 | $8 | $38 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
26 | $28 | $56 |
| Programming of multiple lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with multiple leads to ensure proper function. |
25 | $43 | $118 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
25 | $28 | $84 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $104 | $360 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
23 | $68 | $123 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
18 | $94 | $182 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
14 | $143 | $182 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
13 | $18 | $62 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
11.7% high complexity
45.5% medium
42.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,781
Total received (2018-2024)
Avg $969/year across 7 years
Top 32% in FL for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
362
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$512
2023
$1,076
2022
$1,608
2021
$991
2020
$905
2019
$926
2018
$763
Payments by company (2024)
Alnylam Pharmaceuticals Inc.
$116
Amgen Inc.
$80
Philips North America LLC
$54
Boston Scientific Corporation
$52
E.R. Squibb & Sons, L.L.C.
$46
Janssen Pharmaceuticals, Inc
$42
Novartis Pharmaceuticals Corporation
$37
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
Esperion Therapeutics, Inc.
$19
PFIZER INC.
$17
AstraZeneca Pharmaceuticals LP
$15
CVRx, Inc.
$11
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$603
Abbott Laboratories
$587
Novartis Pharmaceuticals Corporation
$529
SANOFI-AVENTIS U.S. LLC
$498
Janssen Pharmaceuticals, Inc
$398
AstraZeneca Pharmaceuticals LP
$388
Boston Scientific Corporation
$339
Astellas Pharma US Inc
$339
Alnylam Pharmaceuticals Inc.
$336
E.R. Squibb & Sons, L.L.C.
$330
Merck Sharp & Dohme LLC
$325
PFIZER INC.
$253
Amarin Pharma Inc.
$249
Boehringer Ingelheim Pharmaceuticals, Inc.
$213
Philips Electronics North America Corporation
$163
Braemar Manufacturing, LLC
$154
Esperion Therapeutics, Inc.
$145
Merck Sharp & Dohme Corporation
$144
BIOTRONIK INC.
$129
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$118
Actelion Pharmaceuticals US, Inc.
$100
Bayer HealthCare Pharmaceuticals Inc.
$95
Medtronic Vascular, Inc.
$89
Bayer Healthcare Pharmaceuticals Inc.
$80
Philips North America LLC
$54
BOSTON SCIENTIFIC CORPORATION
$33
CVRx, Inc.
$24
Inspire Medical Systems, Inc.
$23
Regeneron Healthcare Solutions, Inc.
$16
Novo Nordisk Inc
$12
Ethicon US, LLC
$12
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · (5050) Extended Holter · (7999) SRC Undivided · (CK7) Extended Holter · AMVUTTRA · BRILINTA · BYDUREON · Barostim Neo System · CAMZYOS · CRT-Ps · Cardiac Monitoring Suite · ClosureFast · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · General - Therapies · INSPIRE · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINX Reflux Management System · LOKELMA · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MERLIN@HOME · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · PRADAXA · PRALUENT · Quadra Assura CRT Defibrillator · RESONATE EL ICD VR · Repatha · Reveal LINQ · TYRX · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
10
County median income
$55,581
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA HIGHLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Siracuse is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 17% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Siracuse experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Siracuse performed 1,012 regadenoson injection (lexiscan) for heart stress test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Siracuse receive payments from pharmaceutical companies?
Yes. Dr. Siracuse received a total of $6,781 from 31 companies across 362 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Siracuse's costs compare to other cardiologists in Sebring?
Dr. Siracuse's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Siracuse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Sebring
Browse cardiologists in Sebring ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology